Zero Stage Capital
41
11M
26
0.95
7
0.37
11
- Stages of investment
- Areas of investment
Summary
In 1981 was created Zero Stage Capital, which is appeared as VC. The company was established in North America in United States. The leading representative office of defined VC is situated in the Boston.
We can highlight the next thriving fund investment areas, such as Biopharma, Pharmaceutical. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Jenzabar, eYak (Sonexis), Powerspan. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The increased amount of exits for fund were in 2009. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2000. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Zero Stage Capital performs on 4 percentage points less the average number of lead investments. Considering the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations.
This organization was formed by Gordon Baty.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Zero Stage Capital, startups are often financed by Lazard Technology Partners, Pilot House Ventures, PJC. The meaningful sponsors for the fund in investment in the same round are Lazard Technology Partners, CB Health Ventures, Pilot House Ventures. In the next rounds fund is usually obtained by New Enterprise Associates, Vanguard Ventures, DFJ.
Investments analytics
Analytics
- Total investments
- 41
- Lead investments
- 7
- Exits
- 11
- Rounds per year
- 0.95
- Follow on index
- 0.37
- Investments by industry
- Software (10)
- Manufacturing (9)
- Biotechnology (6)
- Solar (5)
- Health Care (5) Show 50 more
- Investments by region
-
- United States (39)
- United Kingdom (1)
- Peak activity year
- 2000
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 162M
- Group Appearance index
- 0.80
- Avg. company exit year
- 13
- Avg. multiplicator
- 0.16
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Mothernature.com | 15 Jan 1999 | Internet, Retail | Early Stage Venture | 15M | United States, Massachusetts |
| Proxidyne | 04 Jan 2016 | Retail Technology, Mobile Apps, Internet of Things, Wireless | Seed | 860K | United States, Illinois, Naperville |
| Spherics | 12 May 2005 | Health Care, Medical, Therapeutics | Late Stage Venture | 26M |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.